Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression
Open Access
- 1 December 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (49) , 41047-41056
- https://doi.org/10.1074/jbc.m503713200
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Resistance of Follicular Lymphoma Cells to Chemotherapy Is More Than Just Bcl-2Cancer Biology & Therapy, 2003
- A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: Two complementary signals to overcome cross-resistancePublished by Elsevier ,2002
- Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cellsNature Medicine, 2001
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- Apoptosis control by death and decoy receptorsPublished by Elsevier ,1999
- A novel receptor for Apo2L/TRAIL contains a truncated death domainCurrent Biology, 1997
- TRAIL-R2: a novel apoptosis-mediating receptor for TRAILThe EMBO Journal, 1997
- Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy ReceptorsScience, 1997
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997